That last analysis was conducted due to several MHC risk variants, particularly the class II HLA genes (e.g., HLA-DPB1), having a known substantial impact on genetic predisposition to HNSCC [21, 41]. This evidence concerns the gene HLA-C and head and neck squamous cell carcinoma.